GO:0003953 NAD+ nucleosidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003953 NAD+ nucleosidase activity catalyzes the hydrolysis of NAD+ to ADP-D-ribose and nicotinamide, a central reaction in NAD+ metabolism.
• The reaction is mediated by enzymes such as CD38, SARM1, and bacterial antiphage NADases, which share structural features but differ in regulation.
• NAD+ nucleosidase activity controls cellular NAD+ levels, influencing aging, mitochondrial function, and immune defense.
• Dysregulated NAD+ nucleosidase activity is implicated in neurodegeneration, cancer, and metabolic disorders.
• CRISPR knockout, point mutation, and knock-in models are essential to dissect the physiological roles of NAD+ nucleosidases.
• EDITGENE provides comprehensive CRISPR services to study NAD+ nucleosidase activity in disease and immunity.
Description
NAD+ nucleosidase activity (GO:0003953) is a fundamental enzymatic function that cleaves NAD+ into ADP-D-ribose and nicotinamide, thereby regulating the cellular NAD+ pool. This activity is executed by a diverse family of enzymes, including the mammalian CD38 and SARM1, as well as bacterial antiphage defense proteins such as DSR2 and Sir2-HerA systems. The reaction is critical for maintaining NAD+ homeostasis, which is linked to aging, mitochondrial function, and immune responses. Researchers study NAD+ nucleosidases to understand how NAD+ depletion contributes to age-related diseases and to develop therapeutic strategies targeting these enzymes. The enzymatic activity is tightly regulated, often through auto-ADP-ribosylation or allosteric activation by nucleic acids. Given its broad impact on cell biology, GO:0003953 is a key target for genetic and pharmacological interrogation.
NAD+ nucleosidase activity At A Glance
| GO ID | GO:0003953 |
|---|---|
| GO term | NAD+ nucleosidase activity |
| Ontology | molecular_function |
| Synonym | NADase activity; NAD glycohydrolase activity; DPNase activity |
| Major function | Hydrolysis of NAD+ to ADP-D-ribose and nicotinamide |
| Reaction | NAD+ + H2O = ADP-D-ribose + nicotinamide + H+ |
| Cofactors | None required; some enzymes are regulated by auto-ADP-ribosylation |
| Regulation | Allosteric activation by nucleic acids in prokaryotic systems |
What Is GO:0003953?
NAD+ nucleosidase activity is defined as the catalysis of the reaction: NAD+ + H2O = ADP-D-ribose + nicotinamide + H+. This hydrolysis reaction breaks the glycosidic bond between nicotinamide and the ADP-ribose moiety of NAD+, producing free nicotinamide and ADP-ribose. The activity is synonymous with NADase, NAD glycohydrolase, and DPNase, reflecting its role in NAD+ catabolism.
Why Is NAD+ nucleosidase activity Important in Cell Biology?
NAD+ nucleosidase activity is crucial because it directly controls the availability of NAD+, a coenzyme central to redox reactions, energy metabolism, and signaling. Dysregulation of this activity leads to NAD+ decline, which is a hallmark of aging and contributes to mitochondrial dysfunction and neurodegeneration. In immunity, bacterial NADases such as those in Sir2-HerA and DSR2 systems deplete NAD+ to defend against phage infection, highlighting their evolutionary significance. Understanding GO:0003953 provides insights into diverse biological processes and offers therapeutic targets for age-related diseases and infections.
• Regulates cellular NAD+ levels, impacting energy metabolism and redox balance.
• Implicated in age-related NAD decline and mitochondrial dysfunction.
• Plays a role in axon degeneration through SARM1 activation.
• Mediates antiphage defense in bacteria via NAD+ depletion.
• Involved in immune signaling and cell death pathways.
• Target for cancer therapy due to NAD+ dependency of tumor cells.
• Modulated by auto-ADP-ribosylation, affecting enzyme activity.
• Key to understanding longevity and autophagy regulation.
• Provides a model for studying allosteric regulation by nucleic acids.
• Potential therapeutic target for neurodegenerative diseases.
What Happens During NAD+ nucleosidase activity?
Substrate Binding and Catalysis
In simple terms: The enzyme grabs NAD+ and splits it into two pieces.
NAD+ nucleosidases bind NAD+ in their active site, positioning the substrate for hydrolysis. The reaction cleaves the glycosidic bond between nicotinamide and ADP-ribose, releasing both products. Structural studies of SARM1 reveal a conserved catalytic glutamate that facilitates this cleavage.
Product Release and NAD+ Depletion
In simple terms: After splitting, the products are released, lowering NAD+ levels.
Following catalysis, ADP-D-ribose and nicotinamide are released, leading to a decrease in cellular NAD+ concentration. This depletion can trigger downstream effects such as mitochondrial dysfunction and cell death.
Auto-ADP-ribosylation and Regulation
In simple terms: The enzyme can modify itself to control its own activity.
Some NAD+ nucleosidases undergo auto-ADP-ribosylation, where the enzyme transfers ADP-ribose from NAD+ to itself, inhibiting activity. This feedback mechanism prevents excessive NAD+ consumption.
Allosteric Activation in Prokaryotic Systems
In simple terms: In bacteria, nucleic acids can switch on the enzyme.
In Sir2-HerA and short Argonaute systems, binding of nucleic acids triggers conformational changes that activate NADase activity, leading to NAD+ depletion and abortive infection.
Key Genes Involved in GO:0003953 NAD+ nucleosidase activity
The following genes encode enzymes with NAD+ nucleosidase activity or are directly involved in its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD38 | NAD+ glycohydrolase | Age-related NAD decline, mitochondrial function |
| SARM1 | NAD+ nucleosidase | Axon degeneration, neurodegeneration |
| DSR2 | NADase in antiphage defense | Bacterial immunity, phage defense |
| Sir2 | NAD+-dependent deacetylase with NADase activity | Antiphage defense, allosteric regulation |
| HerA | ATPase component of Sir2-HerA | Antiphage defense |
| Ago | Short prokaryotic Argonaute with NADase | Nucleic acid-triggered immunity |
| Nmnat | NAD+ salvage enzyme | NAD+ homeostasis, neuroprotection |
| PARP1 | NAD+ consumer | DNA repair, NAD+ metabolism |
| SIRT1 | NAD+-dependent deacetylase | Longevity, autophagy |
| SIRT3 | Mitochondrial deacetylase | Mitochondrial function, NAD+ decline |
| NAMPT | NAD+ salvage enzyme | NAD+ biosynthesis, aging |
| CD157 | NAD+ glycohydrolase | Immune cell function |
| TIR | NADase in immune signaling | Cell death, immunity |
| ThsA | NADase in Thoeris defense | Antiphage defense |
| ThsB | TIR-domain NADase | Antiphage defense |
| SPARTA | Short Argonaute NADase | Prokaryotic immunity |
| Sirt2 | NAD+-dependent deacetylase | Cell cycle, neurodegeneration |
How Is NAD+ nucleosidase activity Regulated?
NAD+ nucleosidase activity is regulated at multiple levels. Auto-ADP-ribosylation inhibits enzyme activity, providing a feedback loop to prevent excessive NAD+ depletion. In prokaryotic antiphage systems, nucleic acid binding allosterically activates NADase activity, ensuring a rapid response to infection. Additionally, the expression of NAD+ nucleosidases such as CD38 is modulated by inflammatory signals, linking NAD+ metabolism to immune responses. The autophagy-NAD axis also influences NAD+ levels by controlling the availability of NAD+ precursors.
NAD+ nucleosidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD38 | Age-related NAD decline, metabolic dysfunction | CD38 knockout mouse |
| SARM1 | Neurodegeneration, axon degeneration | SARM1 knockout or point mutant mice |
| DSR2 | Phage defense | Bacterial knockout and phage infection assays |
| Sir2 | Antiphage defense | Sir2-HerA knockout in bacteria |
| Ago | Prokaryotic immunity | Short Argonaute knockout in bacteria |
Neurodegeneration
SARM1 activation triggers NAD+ depletion and axon degeneration, a hallmark of neurodegenerative diseases such as peripheral neuropathy and amyotrophic lateral sclerosis. Inhibiting SARM1 NADase activity is a therapeutic strategy to protect neurons.
Aging and Metabolic Disorders
CD38-mediated NAD+ decline contributes to age-related mitochondrial dysfunction and metabolic decline. Elevated CD38 activity is associated with obesity and insulin resistance, making it a target for interventions.
Cancer
NAD+ nucleosidases can influence tumor progression by altering NAD+ availability, which affects DNA repair and cell survival. Targeting NAD+ metabolism is an emerging anticancer strategy.
Infectious Disease and Immunity
Bacterial NADases such as DSR2 and Sir2-HerA mediate antiphage defense by depleting NAD+ in infected cells. Understanding these systems can inform phage therapy and antimicrobial development.
From NAD+ nucleosidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD38 loss prevent age-related NAD decline? | CD38 knockout mouse |
| How does SARM1 activation lead to axon degeneration? | SARM1 point mutation (catalytic dead) knock-in |
| What is the role of DSR2 in phage defense? | DSR2 knockout bacteria |
| How does nucleic acid binding activate Sir2-HerA? | Sir2-HerA point mutations in allosteric site |
| Does overexpression of CD38 accelerate NAD decline? | CD38 overexpression transgenic mouse |
| Can Ago NADase be tagged for localization? | Tagged Ago knock-in in bacteria |
How to Study the NAD+ nucleosidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADase activity assay | NAD+ hydrolysis rate | Enzyme kinetics, inhibitor screening |
| Cryo-EM | Protein structure | Mechanistic studies of SARM1, DSR2 |
| CRISPR knockout screen | Gene essentiality and modifiers | Identify regulators of NAD+ metabolism |
| Metabolomics | NAD+ and metabolite levels | Assess NAD+ decline in aging |
| Western blot | Protein expression | Validate knockout or overexpression |
| qPCR | mRNA levels | Measure gene expression changes |
| Phage infection assay | Bacterial defense | Study antiphage NADases |
| Auto-ADP-ribosylation assay | Enzyme modification | Study regulation of NADase |
Enzymatic Assays
NAD+ nucleosidase activity is measured using fluorometric or colorimetric assays that detect NAD+ consumption or product formation. These assays are used to screen inhibitors and characterize enzyme kinetics.
Structural Biology
Cryo-EM and X-ray crystallography reveal the atomic details of NAD+ binding and catalysis in enzymes like SARM1 and DSR2. These methods guide the design of small-molecule inhibitors.
CRISPR Screens
Genome-wide CRISPR knockout screens identify genes that modulate NAD+ nucleosidase activity and its downstream effects. These screens are powerful for discovering novel regulators.
Metabolomics
Quantitative metabolomics measures NAD+ and its metabolites to assess the impact of NAD+ nucleosidase activity in cells and tissues. This approach is essential for linking enzyme activity to metabolic phenotypes.
How CRISPR Can Be Used to Study GO:0003953 NAD+ nucleosidase activity
Knockout
CRISPR knockout of NAD+ nucleosidase genes such as CD38 or SARM1 allows researchers to assess their contribution to NAD+ decline and disease phenotypes. Knockout models are essential for validating therapeutic targets.
Point Mutation
Introducing catalytic-dead point mutations in SARM1 or DSR2 via CRISPR enables the separation of enzymatic activity from other functions. Such models are critical for understanding mechanism.
Knock-in
Knock-in of tagged versions of NAD+ nucleosidases (e.g., GFP or HA) facilitates localization and interaction studies. This approach is useful for tracking enzyme dynamics in live cells.
Overexpression
Overexpression of CD38 or SARM1 using CRISPR activation or transgenic models can mimic pathological NAD+ depletion. These models help establish causality in disease.
How EDITGENE Supports NAD+ nucleosidase activity Research
Researchers studying NAD+ nucleosidase activity-related genes often need to determine whether a candidate gene is causally involved in NAD+ depletion, immune defense, or neurodegeneration. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for NAD+ nucleosidase activity research.
Frequently Asked Questions About NAD+ nucleosidase activity
What is NAD+ nucleosidase activity?
NAD+ nucleosidase activity (GO:0003953) is the enzymatic hydrolysis of NAD+ into ADP-D-ribose and nicotinamide, regulating cellular NAD+ levels.
What genes are involved in NAD+ nucleosidase activity?
Key genes include CD38, SARM1, DSR2, Sir2, and short Argonaute proteins, each with distinct roles in NAD+ metabolism and immunity.
How is NAD+ nucleosidase activity regulated?
It is regulated by auto-ADP-ribosylation and allosteric activation by nucleic acids in prokaryotic systems.
What diseases are associated with NAD+ nucleosidase activity?
Dysregulation is linked to neurodegeneration, aging, metabolic disorders, and cancer.
What is the reaction catalyzed by NAD+ nucleosidase?
NAD+ + H2O = ADP-D-ribose + nicotinamide + H+.
How can I study NAD+ nucleosidase activity in the lab?
Use enzymatic assays, CRISPR knockouts, structural biology, and metabolomics to measure activity and its effects.
What are the synonyms for NAD+ nucleosidase activity?
Common synonyms include NADase, NAD glycohydrolase, DPNase, and NAD nucleosidase.
Why is NAD+ nucleosidase activity important for immunity?
Bacterial NADases like DSR2 and Sir2-HerA deplete NAD+ to defend against phage infection, a form of abortive infection.
Can CRISPR be used to study NAD+ nucleosidase activity?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect gene function.
What services does EDITGENE offer for NAD+ nucleosidase research?
EDITGENE provides knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
NAD+ nucleosidase activity (GO:0003953) is a central enzymatic function that governs NAD+ homeostasis and impacts aging, immunity, and disease. Understanding its mechanism and regulation through CRISPR-based models will continue to reveal therapeutic opportunities. EDITGENE offers the tools and expertise to accelerate this research.
References
- 1. Camacho-Pereira J et al.. 2016. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.. Cell Metab 23(6):1127-1139 PMID: 27304511
- 2. Shi Y et al.. 2022. Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules.. Mol Cell 82(9):1643-1659.e10 PMID: 35334231
- 3. Wang R et al.. 2024. The structural basis of the activation and inhibition of DSR2 NADase by phage proteins.. Nat Commun 15(1):6185 PMID: 39039073
- 4. Tang D et al.. 2023. Multiple enzymatic activities of a Sir2-HerA system cooperate for anti-phage defense.. Mol Cell 83(24):4600-4613.e6 PMID: 38096825
- 5. Zhen X et al.. 2024. Mechanistic basis for the allosteric activation of NADase activity in the Sir2-HerA antiphage defense system.. Nat Commun 15(1):9269 PMID: 39465277
- 6. Gao X et al.. 2024. Nucleic-acid-triggered NADase activation of a short prokaryotic Argonaute.. Nature 625(7996):822-831 PMID: 37783228
- 7. Wilson N et al.. 2023. The autophagy-NAD axis in longevity and disease.. Trends Cell Biol 33(9):788-802 PMID: 36878731
- 8. Han MK et al.. 1996. Regulation of NAD+ glycohydrolase activity by NAD(+)-dependent auto-ADP-ribosylation.. Biochem J 318 ( Pt 3)(Pt 3):903-8 PMID: 8836136
